X
STAA icon

Xponance’s STAAR Surgical STAA Stock Holding History

Xponance’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,099
Closed -$373K – 1270
2023
Q2 		$373K Sell
7,099
-396
-5% -$24.1K 0.01% 990
2023
Q1 		$479K Buy
7,495
+9
+0.1% +$587 0.01% 926
2022
Q4 		$363K Sell
7,486
-2
-0% -$125 0.01% 992
2022
Q3 		$528K Sell
7,488
-134
-2% -$11.5K 0.01% 827
2022
Q2 		$541K Buy
7,622
+443
+6% +$28.5K 0.01% 827
2022
Q1 		$573K Sell
7,179
-138
-2% -$10.3K 0.01% 836
2021
Q4 		$668K Sell
7,317
-85
-1% -$9.12K 0.01% 784
2021
Q3 		$952K Sell
7,402
-260
-3% -$36.4K 0.02% 582
2021
Q2 		$1.17M Buy
7,662
+2,270
+42% +$299K 0.02% 523
2021
Q1 		$568K Buy
+5,392
New +$540K 0.01% 719

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Xponance's STAA Position: Q3 2023 in Review

Xponance sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 7,099 shares — an estimated $373K sold.

Xponance first reported a position in STAA in Q1 2021 and held it in 10 quarters. The position peaked at $1.17M in Q2 2021. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.

  • Xponance reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
  • Xponance sold 7,099 STAAR Surgical shares in Q3 2023, an estimated $373K.
  • Xponance first reported a position in STAAR Surgical in Q1 2021 and held it in 10 quarters.
  • Xponance's STAAR Surgical position peaked at $1.17M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.

Based on Xponance's 13F filing for Q3 2023, filed 24 Oct 2023.